CollPlant Biotechnologies (CLGN) Cash & Current Investments (2017 - 2025)
CollPlant Biotechnologies (CLGN) posted Cash & Current Investments of $5.9 million for Q4 2025, down 49.18% on a QoQ basis from $11.7 million in Q2 2025, and down 97.71% year-over-year from $259.9 million in Q4 2024.
CollPlant Biotechnologies (CLGN) Cash & Current Investments (2017 - 2025) Analysis & Trends
CollPlant Biotechnologies' Cash & Current Investments history runs 9 years deep, the most recent figure standing at $5.9 million for Q4 2025.
- Quarterly Cash & Current Investments fell 97.71% year-over-year to $5.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.9 million (down 97.71% YoY) and the FY2025 annual result came in at $5.9 million, down 97.71% from the prior year.
- Cash & Current Investments was $5.9 million for Q4 2025 at CollPlant Biotechnologies, down from $11.7 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $213.0 billion in Q4 2021 and bottomed at $5.9 million in Q4 2025.
- A 5-year average of $11.9 billion and a median of $34.8 million in 2022 frame the typical range for Cash & Current Investments.
- Annual changes were most pronounced in 2021 — Cash & Current Investments surged 5746140.84% — and 2022, when it tumbled 99.9%.
- CollPlant Biotechnologies' Cash & Current Investments stood at $213.0 billion in 2021, then tumbled by 99.9% to $217.9 million in 2022, then plunged by 87.65% to $26.9 million in 2023, then jumped by 865.67% to $259.9 million in 2024, then plunged by 97.71% to $5.9 million in 2025.
- Business Quant data shows CLGN's Cash & Current Investments at $5.9 million in Q4 2025, $11.7 million in Q2 2025, and $259.9 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,801.52 Bn | 66,801.23 Bn | - | 283.54 Mn |
| 2 | Nanobiotix | 1,916.61 Bn | 1,916.55 Bn | - | 61.40 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.65 Bn | 466.85 Bn | 1.35 Bn | 4.79 Bn |
| 5 | Vertex Pharmaceuticals | 121.94 Bn | 114.69 Bn | 2.59 Bn | 7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 69.85 Bn | 61.09 Bn | 3.31 Bn | 8.75 Bn |
| 7 | Belite Bio | 63.06 Bn | 63.06 Bn | - | - |
| 8 | Argenx Se | 55.74 Bn | 50.56 Bn | 1.41 Bn | 5.18 Bn |
| 9 | Revolution Medicines | 37.48 Bn | 37.48 Bn | - | - |
| 10 | CollPlant Biotechnologies | 4.63 Mn | 4.63 Mn | -243,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.95 Mn |
| Jun 30, 2025 | 11.71 Mn |
| Dec 31, 2024 | 259.91 Mn |
| Sep 30, 2024 | 256.37 Mn |
| Jun 30, 2024 | 19.16 Mn |
| Mar 31, 2024 | 265.67 Mn |
| Dec 31, 2023 | 26.92 Mn |
| Sep 30, 2023 | 254.98 Mn |
| Jun 30, 2023 | 22.60 Mn |
| Mar 31, 2023 | 30.10 Mn |
| Dec 31, 2022 | 217.86 Mn |
| Sep 30, 2022 | 33.00 Mn |
| Jun 30, 2022 | 36.69 Mn |
| Mar 31, 2022 | 41.50 Mn |
| Dec 31, 2021 | 213.01 Bn |
| Sep 30, 2021 | 26.18 Mn |
| Jun 30, 2021 | 17.85 Mn |
| Mar 31, 2021 | 193.91 Mn |
| Dec 31, 2020 | 3.71 Mn |
| Sep 30, 2020 | 5.39 Mn |